Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

d-KLA Peptide

Copy Product Info
😃Good
Catalog No. TP2656Cas No. 286380-05-0
Alias D-(KLAKLAK)2

d-KLA Peptide, a synthetic pro-apoptotic peptide, selectively targets and induces apoptosis in mitochondria by disrupting the mitochondrial membrane. It activates apoptosis-related biochemical pathways, notably those involving caspase family proteins and PARP (poly ADP ribose polymerase). Additionally, d-KLA Peptide facilitates the delivery of genes or small molecules, amplifying its anti-tumor properties.

d-KLA Peptide

d-KLA Peptide

Copy Product Info
😃Good
Catalog No. TP2656Alias D-(KLAKLAK)2Cas No. 286380-05-0
d-KLA Peptide, a synthetic pro-apoptotic peptide, selectively targets and induces apoptosis in mitochondria by disrupting the mitochondrial membrane. It activates apoptosis-related biochemical pathways, notably those involving caspase family proteins and PARP (poly ADP ribose polymerase). Additionally, d-KLA Peptide facilitates the delivery of genes or small molecules, amplifying its anti-tumor properties.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
d-KLA Peptide, a synthetic pro-apoptotic peptide, selectively targets and induces apoptosis in mitochondria by disrupting the mitochondrial membrane. It activates apoptosis-related biochemical pathways, notably those involving caspase family proteins and PARP (poly ADP ribose polymerase). Additionally, d-KLA Peptide facilitates the delivery of genes or small molecules, amplifying its anti-tumor properties.
SynonymsD-(KLAKLAK)2
Chemical Properties
Molecular Weight1523.99
FormulaC72H138N20O15
Cas No.286380-05-0
Smiles[C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@H](NC([C@@H](CCCCN)N)=O)CC(C)C)=O)C)=O)CCCCN)=O)CC(C)C)=O)C)=O)CCCCN)=O)(C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@H](CCCCN)C(O)=O)=O)C)=O)CC(C)C)=O)CCCCN)=O)C)=O)CC(C)C)=O)CCCCN
Sequenced-{Lys-Leu-Ala-Lys-Leu-Ala-Lys-Lys-Leu-Ala-Lys-Leu-Ala-Lys}
Sequence Shortd-{KLAKLAKKLAKLAK)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy d-KLA Peptide | purchase d-KLA Peptide | d-KLA Peptide cost | order d-KLA Peptide | d-KLA Peptide chemical structure | d-KLA Peptide formula | d-KLA Peptide molecular weight